Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01061320

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Thammasat University (from the registry)
Registry
  • NCT NCT01061320
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Thailand (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01061320. Randomized; double masking; primary purpose prevention. Start 2010-01 (registry gives no type); primary completion 2010-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
Condition
Contrast Induced Nephropathy
Intervention (Drug)
alpha tocopherol
Intervention (Drug)
placebo
Lead sponsor
Thammasat University (class: other)

Record details

Record id
cardio:ct-nct01061320
Content hash
c2e913f4c9762838f657089694a74424fafa3c6bb74b9c2fe2f4249dc4047262